JPMORGAN CHASE & CO

Holdings History for Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS)

Symbol: ATXS
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$9,355,148	714,679	-965,928	-57%	$13.09	Q4 2025
30 Sep 2025	0%	-0%	$12,234,819	1,680,607	-15,464	-0.91%	$7.28	Q3 2025
30 Jun 2025	0%	+0%	$9,090,940	1,696,071	+1,660,039	+4607%	$5.36	Q2 2025
31 Mar 2025	0%	-0%	$192,411	36,032	-18,632		$5.34	Q1 2025
31 Dec 2024	0%	+0%	$488,697	54,664	+15,520	+40%	$8.94	Q4 2024
30 Sep 2024	0%	+0%	$430,976	39,144	+19,735	+102%	$11.01	Q3 2024
30 Jun 2024	0%	0%	$176,621	19,409	-69	-0.35%	$9.10	Q2 2024
31 Mar 2024	0%	-0%	$274,152	19,478	-2,404	-11%	$14.08	Q1 2024
31 Dec 2023	0%	+0%	$168,054	21,882	+4,545	+26%	$7.68	Q4 2023
30 Sep 2023	0%	-0%	$129,334	17,337	-10,256	-37%	$7.46	Q3 2023
30 Jun 2023	0%	+0%	$229,850	27,593	+27,593	NEW	$8.33	Q2 2023
31 Dec 2022		0%	$0	0	-299	-100%	$12.58	Q4 2022
30 Sep 2022	0%	0%	$3,000	299	+299	NEW	$10.03	Q3 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.